
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Vitafoods Europe 2024: Charting the future of Sabinsa Group with the company’s new CEO
04 Jun 2024 | Sabinsa
At this year’s trade show, we caught up with Sabinsa Group’s new CEO, Shaheen Majeed, to discuss the company’s future focus. Majeed detailed the trends, markets and ingredients the company will focus on in the coming years, as well as its R&D plans. He also explained that the company will continue conducting clinical science to verify the efficacy of its ingredients and publish educational books.
Hello everybody, this is William Bradford Nichols, the editor for Nutrition Insight, and I'm here live at Vita Foods Europe in Geneva, Switzerland with Shaheen Majeed, the owner and CEO and global managing director of Sebenza Group.
Hello Shaheen, how are you today?
I'm wonderful, thanks for having me here.
We are excited to talk to you.
Got some questions for you as the new CEO of Sebinza Group.
Can you tell me what direction do you plan on taking Sainza in the coming years?
First, I want to say it's wonderful being here.
Thanks for this opportunity.
I want to give a big thanks to my team here in Europe.
They really made it possible to see the development, to see the growth, and I think just based on that alone, it shows me great opportunities to grow not only in this market and markets outside.
The future for Sainza and the Summit Group is really gonna be quality ingredients that's in our DNA, right?
That's what we're known for and that's gonna continue to happen throughout the course of many years to come.
So can you tell me where you plan on sort of concentrating the company's R&D focus over the next few years and how that aligns with your long term goals?
Absolutely.
We're known for our botanical extracts, and that part of the work is going to continue.
But the microbiome, the probiotics, postbiotics, those are fascinating areas.
They are areas that we're also very familiar with and we're excited to bring more technology and more innovation to that sector, microbiome, probiotics, postbiotics.
What are your plans for company growth over the next 3 years?
The company growth is going to come from a multitude of angles and facets.
One of the easiest ones that we can talk about is collaboration, partnerships with companies that we're already doing business with, but we want to go a little deeper.
We want to be able to bring products out that are.
Natural in terms of both products and the alignment of what they're trying to market and what we're innovating in our labs, we want to be able to showcase our pipeline to a few companies that can accelerate those ingredients to the marketplace for consumer health.
Wonderful.
What markets do you see yourself or do you see as the main growth areas for your ingredients over the next 3 years?
I got to tell you, the biggest market is always going to be the United States.
Some people can argue that's a regulatory framework.
Other people could argue the consumerism aspect.
Europe is a fascinating area, but I got to tell you, don't ignore India and don't ever ignore China.
Those are markets where ingredients have been taken out of.
But I have to admit, and I think people already know this, there are consumers there as , right?
All the products that are either produced, extracted in India or China being shipped out.
Guess what, there are consumers right there.
So those two markets are the ones to really watch for, and we're excited that we're already there, and we're going to bring health health and wellness to millions and millions of people.
And finally, can you tell us what's next?
What's the next big thing we can expect from Sidenza Group?
I think you know this is a question that's on everybody's mind, right?
So since the passing of Doctor Mohammad Najed, my father.
People are looking towards what's the very next thing that's coming out and true to his essence.
We're going to continue writing books.
He was a fanatic about it.
He loved his books.
We're going to continue with that, so there's going to be education that will continue on behalf of Doctor Majeed and the Sabina Group.
There are going to be ingredients that are coming out with extreme clinical substantiation.
We're no longer going to put ingredients out or on a product list without giving quality science and quality clinical work to give you the benefits that you can talk about with your customers.
Shahin, thank you so much for sharing your insights with us today.
Hope you have a great rest of your Vita Foods experience, and we look forward to hearing much more from Sebenzo in the future.
Thank you so much.
















